Adverse events associated with interactions with dietary and herbal supplements among inpatients

British Journal of Clinical Pharmacology

Volumn 83, Issue 4, 2017, Pages 836-845

  Levy, Ilana ^a   Attias, Samuel ^a,b   Ben Arye, Eran ^c,d   Goldstein, Lee ^c,e   Schiff, Elad ^a,c  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d CLALIT HEALTH SERVICES   (Israel)

^e HAEMEK MEDICAL CENTER   (Israel)

Author keywords

complementary medicine; drug interactions; herbal medicine

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; CALCIUM; CASEIN; CHAMOMILE; CLOPIDOGREL; CRANBERRY EXTRACT; CYANOCOBALAMIN; CYTOCHROME P450 2C9; DIGOXIN; ENOXAPARIN; FISH OIL; FOLIC ACID; GLUCOSAMINE; HERBACEOUS AGENT; IRON; LERCANIDIPINE; LEVOTHYROXINE; METHADONE; OMEGA 3 FATTY ACID; PEPPERMINT OIL; ROSMARINUS OFFICINALIS EXTRACT; SIMVASTATIN; TURMERIC; UBIDECARENONE; UNINDEXED DRUG; VITAMIN B COMPLEX; VITAMIN D; WARFARIN;

ADULT; ALOYSIA CITRODORA; ANEMIA; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CAUSALITY; COMORBIDITY; CRANBERRY; CROSS-SECTIONAL STUDY; DIETARY AND HERBAL SUPPLEMENT; DIETARY SUPPLEMENT; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; ENDOCRINE DISEASE; EXTERNAL VALIDITY; FAINTNESS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOLOGIC MALIGNANCY; HERB DRUG INTERACTION; HOSPITAL PATIENT; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOTENSION; HYPOTHYROIDISM; HYSSOPUS OFFICINALIS; INTERNAL MEDICINE; INTERNATIONAL NORMALIZED RATIO; ISRAEL; LINSEED; MAJOR CLINICAL STUDY; MALE; MELENA; METABOLIC DISORDER; OPERATIVE BLOOD LOSS; ORTHOSTATIC HYPOTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY FAILURE; RISK ASSESSMENT; ROSEMARY; SAMPLE SIZE; SURGICAL WARD; TEA; AGED; HOSPITALIZATION; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL; VERY ELDERLY;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HERB-DRUG INTERACTIONS; HOSPITALIZATION; HUMANS; INPATIENTS; ISRAEL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 85005784388     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.13158     Document Type: Article

References (47)

1. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP, et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 2016; 44: D1054–D1068.
2. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, et al. The Concise Guide to PHARMACOLOGY 2015/16: Transporters. Br J Pharmacol 2015; 172: 6110–6202.
3. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE, et al. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 2015; 172: 6024–6109.
4. De Smet PA. Herbal remedies. N Engl J Med 2002; 347: 2046–2056.
5. Lavy T, Haran B, Shemer J, Shani S. Regulation of natural medicines in Israel and abroad. Harefuah 2000; 139: 339–344.
6. Giveon SM, Liberman N, Klang S, Kahan E. Are people who use ‘natural drugs’ aware of their potentially harmful side effects and reporting to family physician? Patient Educ Couns 2004; 53: 5–11.
7. Goldstein LH, Elias M, Ron-Avraham G, Biniaurishvili BZ, Mad-jar M, Kamargash I, et al. Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. Br J Clin Pharmacol 2007; 64: 373–380.
8. Qadour E, Ben-Arye E, Goldstein L, Attias S, Schiff E. Dietary supplements use during hospitalization. Harefuah 2015; 154: 39–42.
9. Dietary Supplements Health and Education Act. 1994. Available at https://ods.od.nih.gov/About/dshea_wording.aspx (last accessed 15 June 2015).
10. Goodnight SH Jr, Harris WS, Connor WE. The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood 1981; 58: 880–885.
11. Herb Research Foundation. Available at http://www.herbs.org/current/sjwfrance.htm (last accessed 29 September 2015).
12. Borrelli F, Izzo AA. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J 2009; 11: 710–727.
13. Fukunaga K, Orito K. Time-course effects of St John's wort on the pharmacokinetics of cyclosporine in dogs: interactions between herbal extracts and drugs. J Vet Pharmacol Ther 2012; 35: 446–451.
14. Sim SN, Levine MA. An evaluation of pharmacist and health food store retailer's knowledge regarding potential drug interactions associated with St. John's wort. Can J Clin Pharmacol 2010; 17: e57–e63.
15. Murakami Y, Tanaka T, Murakami H, Tsujimoto M, Ohtani H, Sawada Y. Pharmacokinetic modelling of the interaction between St John's wort and ciclosporin A. Br J Clin Pharmacol 2006; 61: 671–676.
16. Graham RE, Gandhi TK, Borus J, Seger AC, Burdick E, Bates DW, et al. Risk of concurrent use of prescription drugs with herbal and dietary supplements in ambulatory care. In: Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 4: Technology and Medication Safety), eds Henriksen K, Battles JB, Keyes MA, Grady ML. Rockville, MD: Agency for Healthcare Research and Quality.
17. Mouly S, Morgand M, Lopes A, Lloret-Linares C, Bergmann JF. Drug–food interactions in internal medicine: what physicians should know? Rev Med Interne 2015; 36: 530–539.
18. Gardiner P, Filippelli AC, Sadikova E, White LF, Jack BW. Medication and dietary supplement interactions among a low-income, hospitalized patient population who take cardiac medications. Evid Based Complement Alternat Med 2015; 2015: 429826.
19. Alsanad SM, Williamson EM, Howard RL. Cancer patients at risk of herb food supplement–drug interactions – a systematic review. Phytother Res 2014; 28: 1749–1755.
20. Donaldson M, Touger-Decker R. Dietary supplement interactions with medications used commonly in dentistry. J Am Dent Assoc 2013; 144: 787–794.
21. Sood A, Sood R, Brinker FJ, Mann R, Loehrer LL, Wahner-Roedler DL. Potential for interactions between dietary supplements and prescription medications. Am J Med 2008; 121: 207–211.
22. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–245.
23. Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007; 41: 674–680.
24. Ben-Arye E, Halabi I, Goldstein L, Attias S, Schiff E. Asking patients the right questions about herbal and dietary supplements: cross-cultural perspectives. Complement Ther Med 2014; 22: 304–310.
25. Ben-Arye E, Attias S, Levy I, Goldstein L, Schiff E. Mind the gap: disclosure of dietary supplement use to hospital and family physicians. Patient Educ Couns 2016. doi:10.1016/j.pec.2016.07.037.
26. Levy I, Attias S, Ben Arye E, Goldstein L, Schiff E. Interactions between dietary supplements in hospitalized patients. Intern Emerg Med 2016; 11: 917–927.
27. Attias S, Levy I, Ben Arye E, Matter I, Sroka G, Grimberg O, et al. Consumption of herbal and dietary supplement in patients undergoing bariatric surgery: cross-sectional prospective study. Bariatr Surg Pract Patient Care 2016; 11: 30–36.
28. Natural Medicines Comprehensive Database. Available at http://naturaldatabase.therapeuticresearch.com (last accessed 15 June 2015).
29. Boletim de Farmaco Vigilancia. Available at http://www.infarmed.pt/boletim_farmacovigilancia/13_2/default_uk.htm (last accessed 6 October 2015).
30. Schiff E, Frenkel M, Shilo M, Levy M, Schachter L, Freifeld Y, et al. Bridging the physician and CAM practitioner communication gap: suggested framework for communication between physicians and CAM practitioners based on a cross professional survey from Israel. Patient Educ Couns 2011; 85: 188–193.
31. Wirsansky I. Educational interventions for developing awareness and imparting skill questioning about use of dietary and herbal supplements among hospitalized patients. Fundamental Sciences thesis. Technion – Israel Institute of Technology, 2012.
32. Wittkowsky AK. Dietary supplements, herbs and oral anticoagulants: the nature of the evidence. J Thromb Thrombolysis 2008; 25: 72–77.
33. Knop J, Misaka S, Singer K, Hoier E, Muller F, Glaeser H, et al. Inhibitory effects of green tea and (−)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-glycoprotein. PLoS One 2015; 10: e0139370.
34. Srivastava KC, Bordia A, Verma AK. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 223–227.
35. Hellum BH, Nilsen OG. The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol. Basic Clin Pharmacol Toxicol 2007; 101: 350–358.
36. Hellum BH, Nilsen OG. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol 2008; 102: 466–475.
37. Dresser GK, Wacher V, Wong S, Wong HT, Bailey DG. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Clin Pharmacol Ther 2002; 72: 247–255.
38. Ho MJ, Bellusci A, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension (review). Cochrane Database Syst Rev 2009; CD007435.
39. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 2002; 277: 25125–25132.
40. Troft I, Bonaa KH, Ingebretsen OC, Nordøy A, Jenssen T. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med 1995; 123: 911–918.
41. Townsend RR, McFadden CB, Ford V, Cadee JA. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am J Hypertens 2004; 17: 1056–1058.
42. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA 2000; 283: 2822–2825.
43. Campbell NRC, Hasinoff BB, Stalts H, Rao B, Wong NCW. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med 1992; 117: 1010–1013.
44. Gloth FM III, ed. Handbook of Pain Relief in Older Adults: An Evidence-Based Approach, 2nd edn. New York: Humana Press, 2011.
45. Burke V, Hodgson JM, Beilin LJ, Giangiulioi N, Rogers P, Puddey IB. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension 2001; 38: 821–826.
46. MacKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res 2006; 20: 519–530.
47. Cochrane ML. Inhibition of cytochrome P450 2C9 by essential oils. MSc Thesis, University of North Carolina at Greensboro, 2015.